Product Information

TRAVATAN Z 0.004% EYE DROP is a brand product labeled by Sandoz Inc., priced at $94.2806 per ML under NDC 66758009575. Its NADAC has been published 107 times since Nov 6, 2024.

FDA first approved this application on Sep 21, 2006. Its Orange Book therapeutic-equivalence code is AT2.

TRAVATAN Z 0.004% EYE DROP

travoprost
$94.2806per ML

Strength

.04 mg/mL

Manufacturer

Sandoz Inc.

NDC

66758009575

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TRAVOPROST

Approval Type

New Drug (NDA)

FDA Application

NDA021994

FDA Approved

9/21/2006

TE Code

AT2

On Market Since

10/20/2006

Pharmacological Classes

Prostaglandin Analog
Prostaglandins

Price Statistics

The NADAC for TRAVATAN Z 0.004% EYE DROP has been published 107 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$94.2806 per ML
All-time high$94.5660 (Jan 15, 2025)
All-time low$94.2806 (Nov 18, 2026)
52-week high$94.4898
52-week low$94.2806
Median price$94.4384
Average price$94.4239
Largest weekly change-0.2% (Jan 22, 2025)
Weeks tracked107
Tracking sinceNov 6, 2024

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRAVATAN Z 0.004% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TRAVATAN Z 0.004% EYE DROP, manufactured by Sandoz Inc., is $94.2806 per ML (NDC 66758009575), effective Nov 18, 2026.

How has the price of TRAVATAN Z 0.004% EYE DROP changed over time?

Over the history we have for it, the NADAC for TRAVATAN Z 0.004% EYE DROP has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for TRAVATAN Z 0.004% EYE DROP?

Since Nov 6, 2024, the NADAC for TRAVATAN Z 0.004% EYE DROP has ranged from a low of $94.2806 (Nov 18, 2026) to a high of $94.5660 (Jan 15, 2025), with a median of $94.4384 per ML.

Are there cheaper alternatives to TRAVATAN Z 0.004% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVATAN Z 0.004% EYE DROP, is $94.2031 per ML — about 0% below TRAVATAN Z 0.004% EYE DROP.

Who manufactures TRAVATAN Z 0.004% EYE DROP?

TRAVATAN Z 0.004% EYE DROP (NDC 66758009575) is labeled by Sandoz Inc., and CMS classifies it as a brand product.